News | etectRx

etectRx Announces Eric Buffkin as New CEO

7/30/2021

Company Founder Takes the Helm of etectRx, a Digital Health Company GAINESVILLE, Fla. (August 2, 2021) – etectRx™, Inc. (etectRx™), a privately held digital health...

etectRx Announces Launch of MyTPill Study to Address Medication Adherence Among HIV+ Prescription Opioid Users

5/4/2021

GAINESVILLE, Fla. & BOSTON, Mass. (May 4, 2021) – Digital health company, etectRx, Inc., today announced the launch of a study to monitor antiretroviral therapy...

WHITEPAPER: The Extraordinary Problem of Medication Nonadherence in Oncology Patients And How Digital Pills Can Make a Difference

5/4/2021

Cancer is often highly treatable due to new therapies, especially oral agents, that have improved outcomes and survival rates, and allow patients to be treated...

etectRx “It Already Does That”

4/30/2021

Inspiration struck the etectRx team after watching the Apple Watch Series 6 – “It Already Does That” campaign. etectRx enthusiastically created its version of “It...

A Brief Training Program to Support the Use of a Digital Pill System for Medication Adherence: Pilot Descriptive Study

4/23/2021

In partnership with our collaborators at academic medical centers in the United States, etectRx has created a simple and streamlined training program for our FDA-cleared...

The ID-Cap™ System: A Physician’s Perspective

4/14/2021

“The overall experience of our study participants so far with the ID-Cap System has been very positive. They have been able to navigate it quite...

High Patient Engagement with the ID-Cap™ System on 98.0% of Use-Days in a Clinical Study During the COVID-19 Pandemic

4/12/2021

COVID-19 caused many interruptions in clinical trials. After a brief pause in external clinical research, clinical studies involving use of the FDA-cleared ID-Cap System from...

Digital Pill Study Shows Significant Impact on Hepatitis C Treatment Adherence and Efficacy

3/5/2021

A study conducted between August 2017 and April 2019 with 288 participants for hepatitis C virus (HCV) treatment evaluated the impact of a digital medicine...

etectRx Targets Mental Health Field In Partnership With Local Health Pharmacy

2/26/2021

GAINESVILLE, Fla. (February 26, 2021) – Digital health company, etectRx, Inc., announced a signed letter of intent for a novel partnership with Local Health, Inc.,...

Digital Pill Company etectRx Selects Biotech Leader as VP of Product Management

2/22/2021

GAINESVILLE, Fla. (February 22, 2021) – Digital health company, etectRx, Inc. recently announced Adam Standley as vice president of product management. In his new role,...

Failure Risk in Clinical Trials? An Easy-to-Swallow Solution

2/19/2021

Our CEO Valerie Sullivan speaks in PharmaVOICE about failing clinical trials and our easy solution: the etectRx digital pill ID-Cap™ System. With our technology, there is no reason for clinical trial...

etectRx Announces Agreement to Advance Digital Sensors for Medication Adherence in Combination with Prescription Digital Therapeutics

1/14/2021

GAINESVILLE, Fla. (January 14, 2021) – Digital health company, etectRx, Inc., announced today that it has entered into an agreement with Pear Therapeutics, Inc. to...